• 1
    Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter HJ, Koonin E, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505508.
  • 2
    Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334: 15361537.
  • 3
    Simons JN, Leary TP, Dawson GJ. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564569.
  • 4
    Bowden DS, Moaven LD, Locarnini SA. New hepatitis viruses: are there enough letters in the alphabet? Med J Aust 1996; 164: 8789.
  • 5
    Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 23: 14851490.
  • 6
    Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, Kim JP, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741746.
  • 7
    Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih WK, Kim JP. The incidence of transfusion associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747754.
  • 8
    Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown etiology. Lancet 1995; 346: 11311132.
  • 9
    Hiramatsu N, Dash S, Sullivan D, Fiel MI, Atillasoy E, Thung SN, Miller CM, et al. Detection of hepatitis G virus (HGV) sequences in liver tissues of patients with fulminant hepatic failure [Abstract]. Gastroenterology 1996; 110: A1212.
  • 10
    Jeffers LJ, Piatak M, Bernstein DE, Reddy KR, Lifson JD, Yun A, Coelho-Little E, et al. Hepatitis G virus infection in patients with acute and chronic liver disease of unknown etiology [Abstract]. Hepatology 1995; 22: 182A.
  • 11
    Pessoa MG, Terrault NA, Ferrell L, Kim JP, Kolberg J, Detmer J, Collins M, et al. Detection and quantitation of hepatitis G virus (HGV) in patients with cryptogenic liver disease undergoing liver transplantation [Abstract]. Gastroenterology 1996; 110: A1294.
  • 12
    Oelsner DH, Caldwell SH, Kim JP, Yun A. Hepatitis G virus prevalence in a cryptogenic cirrhotic population [Abstract]. Gastroenterology 1996; 110: A1282.
  • 13
    DiBisceglie AM, Bacon BR, Neuschwnader-Tetri BA, Yun A, Kim JP. Role of hepatitis G virus in cryptogenic liver disease [Abstract]. Gastroenterology 1996; 110: A1181.
  • 14
    Terrault NA, Piatak M, Kim JP, Kolberg J, Collins M, Detmer J, Yun A, et al. New method for hepatitis G virus (HGV) RNA quantitation in liver transplant (OLT) recipients with HBV/HGV coinfection [Abstract]. Gastroenterology 1996; 110: A1344.
  • 15
    Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JYN, Lake JR, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996; 111: 15691575.
  • 16
    Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Coombs KM, Fennessy S, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317322.
  • 17
    Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 11371143.
  • 18
    Gretch DR, Bacci CE, Corey L, Rosa C Dela, Lesniewski RR, Kowdley K, Gown A, et al. Persistent hepatitis C infection after liver transplantation: clinical and virological features. Hepatology 1995; 22: 19.
  • 19
    Gane EJ, Naoumov NV, Qian K, Mondelli MU, Maertens G, Portmann BC, Lau JYN, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167177.
  • 20
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815820.
  • 21
    Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 10881096.
  • 22
    Villa E, Grottola A, Buttafoco P, Merighi A, Ferretti I, Trande P, Zoboli P, et al. Long-term follow-up of hepatitis C virus (HCV) infection in liver transplant patients. Clin Transplant 1995; 9: 160164.
  • 23
    Gretch D, Wile M, Gaur L, Lesniewski R, Nelson K, Strong M, Johnson R, et al. Donor-recipient match at the HLA-DQB locus is associated with recrudescence of chronic hepatitis following liver transplantation for end stage hepatitis C [Abstract]. Hepatology 1993; 18: 108A.
  • 24
    Gretch DR, Polyak S, Wilson J, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996; 70: 76227631.
  • 25
    Gretch D, Lee W, Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 1992; 30: 21452149.
  • 26
    Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673679.
  • 27
    Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, Seed CRG, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 11971204.
  • 28
    Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish T, Irvine B, Beall E, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 23912399.
  • 29
    Hadziyannis S, Wages J, Kim JP, Karayiannis P, Hess G, Piatak M, Lifson J, et al. Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products [Abstract]. J Hepatol 1995; 23: 78.
  • 30
    Chokshi S, Tzampouras N, Gane E, Smith HM, Naoumov NV, Williams R. The impact of hepatitis GBV-C / HGV agent in patients transplanted for HCV-cirrhosis [Abstract]. Hepatology 1996; 24: 419A.
  • 31
    Poutous A, Vargas H, Laskus T, Wang L, Radkowski M, Lee R, Demetris J, et al. Hepatitis G virus infection in HCV-positive liver transplant recipients [Abstract]. Hepatology 1996; 24: 420A.
  • 32
    Rosen HR, Martin P, Shackleton CR, Farmer DA, Holt C, Busuttil RW. OKT3 use associated with diminished graft and patient survival in patients transplanted for chronic hepatitis C [Abstract]. Hepatology 1995; 22: 132A.
  • 33
    Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 3034.
  • 34
    O'Grady JG, Sutherland S, Harvey F, Calne RY, Alexander GJM, Donaldson PT, Portmann B, et al. Cytomegalovirus infection and donor/ recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988: 2: 302305.